230 related articles for article (PubMed ID: 19884269)
1. Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.
Kakumanu P; Sobel ES; Narain S; Li Y; Akaogi J; Yamasaki Y; Segal MS; Hahn PC; Chan EK; Reeves WH; Satoh M
J Rheumatol; 2009 Dec; 36(12):2682-90. PubMed ID: 19884269
[TBL] [Abstract][Full Text] [Related]
2. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
Taraborelli M; Inverardi F; Fredi M; Ceribelli A; Cavazzana I; Tincani A; Franceschini F
Reumatismo; 2012 Dec; 64(5):321-5. PubMed ID: 23256108
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
Ziegelasch M; van Delft MA; Wallin P; Skogh T; Magro-Checa C; Steup-Beekman GM; Trouw LA; Kastbom A; Sjöwall C
Arthritis Res Ther; 2016 Dec; 18(1):289. PubMed ID: 27912793
[TBL] [Abstract][Full Text] [Related]
4. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
5. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
[TBL] [Abstract][Full Text] [Related]
6. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.
Damián-Abrego GN; Cabiedes J; Cabral AR
Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411
[TBL] [Abstract][Full Text] [Related]
7. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Budhram A; Chu R; Rusta-Sallehy S; Ioannidis G; Denburg JA; Adachi JD; Haaland DA
Lupus; 2014 Oct; 23(11):1156-63. PubMed ID: 24990382
[TBL] [Abstract][Full Text] [Related]
9. Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients.
Skare TL; Nisihara R; Barbosa BB; da Luz A; Utiyama S; Picceli V
Clin Rheumatol; 2013 Jul; 32(7):1065-70. PubMed ID: 23412637
[TBL] [Abstract][Full Text] [Related]
10. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
Mediwake R; Isenberg DA; Schellekens GA; van Venrooij WJ
Ann Rheum Dis; 2001 Jan; 60(1):67-8. PubMed ID: 11114286
[TBL] [Abstract][Full Text] [Related]
11. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
12. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
[TBL] [Abstract][Full Text] [Related]
13. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
Popescu C; Zofotă S; Bojincă V; Ionescu R
Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
15. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Toes RE; Huizinga TW
Arthritis Res Ther; 2005; 7(5):R949-58. PubMed ID: 16207336
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
18. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide.
Kakumanu P; Yamagata H; Sobel ES; Reeves WH; Chan EK; Satoh M
Arthritis Rheum; 2008 Jun; 58(6):1576-81. PubMed ID: 18512773
[TBL] [Abstract][Full Text] [Related]
19. A study of erosive phenotypes in lupus arthritis using magnetic resonance imaging and anti-citrullinated protein antibody, anti-RA33 and RF autoantibody status.
Ball EM; Tan AL; Fukuba E; McGonagle D; Grey A; Steiner G; Bell AL; Rooney MR
Rheumatology (Oxford); 2014 Oct; 53(10):1835-43. PubMed ID: 24850876
[TBL] [Abstract][Full Text] [Related]
20. Relatedness of Antibodies to Peptides Containing Homocitrulline or Citrulline in Patients with Rheumatoid Arthritis.
Lac P; Racapé M; Barra L; Bell DA; Cairns E
J Rheumatol; 2018 Mar; 45(3):302-309. PubMed ID: 29196382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
